Relmada Therapeutics, Inc. · NASDAQ:RLMD

Commodore Capital LP reported a 5.10% stake in Relmada Therapeutics, Inc. (Schedule 13G)

Event Apr 27, 2026 · Filed May 4, 2026

Commodore Capital LP reported a 5.10% stake in Relmada Therapeutics, Inc., 5,505,527 shares, as a passive investor on Apr 27, 2026. Filed May 4, 2026 (Schedule 13G).

Stake
5.10%
Shares
5,505,527
Intent
Passive
What changed
Crossed above 5%
Filed together
4 holders

The filing in full

HolderStakeShares
Commodore Capital LP5.10%5,505,527
Commodore Capital Master LP5.10%5,505,527
Robert Egen Atkinson5.10%5,505,527
Michael Kramarz5.10%5,505,527

Source

View original at SEC

Related